Schiff Andrew N (CIK 0001172252)

Latest company ownership

Shares held
10,100,000
Last filed at
Jul 15, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q3 2025Q4
ADMA - ADMA BIOLOGICS, INC.
Role: 10% Owner
Shares held
3,620,143
Last filed at
Oct 23, 2013
Confidence Score
50.0
2025Q4
Confidence Score History
2013Q4 2025Q4
TTOO - T2 Biosystems, Inc.
Role: 10% Owner
Shares held
2,830,992
Last filed at
Dec 9, 2015
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q3 2025Q4
Shares held
1,837,125
Last filed at
Apr 27, 2015
Confidence Score
50.0
2025Q4
Confidence Score History
2013Q3 2025Q4
Shares held
4,793
Last filed at
Jun 10, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 10, 2022 Nov 14, 2022 Aclaris Therapeutics, Inc. Director Sell 22.5 -53,926 -11.04% ✓ $919.6K
Oct 24, 2022 Oct 26, 2022 Aclaris Therapeutics, Inc. Director Sell 26.3 -41,174 -7.78% ✓ $700.4K
Oct 17, 2022 Oct 19, 2022 Aclaris Therapeutics, Inc. Director Sell 26.3 -52,037 -8.95% ✓ $862.1K
Oct 7, 2022 Oct 11, 2022 Aclaris Therapeutics, Inc. Director Sell 45.0 -7,324 -1.24% ✓ $118.3K
Oct 4, 2022 Oct 6, 2022 Aclaris Therapeutics, Inc. Director Sell 30.0 -45,539 -7.18% ✓ $749K
Jun 17, 2022 Jun 21, 2022 Aclaris Therapeutics, Inc. Director Sell 38.8 -19,565 -2.99% ✓ $296.3K
Jul 15, 2019 Jul 15, 2019 Viracta Therapeutics, Inc. 10% Owner Buy 100.0 +2,500,000 32.89% ✗ $1.5M
Aug 16, 2017 Aug 16, 2017 Aclaris Therapeutics, Inc. Director Buy 100.0 +108,601 20.65% ✗ $2.5M
Dec 9, 2015 Dec 9, 2015 T2 Biosystems, Inc. 10% Owner Buy 100.0 +307,692 12.19% ✗ $3M
Apr 23, 2015 Apr 27, 2015 Esperion Therapeutics, Inc. 10% Owner Sell 15.0 -217,469 -5.49% ✗ $23.5M
Aug 12, 2014 Aug 14, 2014 T2 Biosystems, Inc. 10% Owner Buy 100.0 +454,545 21.97% ✗ $5M
Oct 22, 2013 Oct 23, 2013 ADMA BIOLOGICS, INC. 10% Owner Buy 100.0 +411,765 12.83% ✗ $3.5M
Jul 1, 2013 Jul 1, 2013 Esperion Therapeutics, Inc. 10% Owner Buy 100.0 +238,119 13.11% ✗ $3.3M